Cell reports. Medicine

Propionate levels linked to disease activity in children with multiple sclerosis

Updated

Abstract

Propionate is consistently associated with a protective effect on multiple sclerosis outcomes.

  • Short-chain fatty acids (SCFAs) are produced by the fermentation of dietary fibers and may influence the gut-brain axis in multiple sclerosis (MS).
  • Analysis of plasma and stool samples from a large cohort shows that higher levels of propionate correlate with lower disease activity in MS.
  • Findings are validated in a separate large cohort, reinforcing the association between propionate and reduced clinical activity.
  • There is a lack of correlation between propionate levels and dietary fiber intake, indicating that dietary changes alone may not effectively alter SCFA levels.
  • The results suggest that administering propionate directly could be more beneficial than simply increasing fiber intake in managing MS.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free